4 results
The primary objective of this study is to assess the objective response rates (ORR) for two starting doses of vandetanib, 150 mg and 300 mg in patients with unresectable locally advanced or metastatic MTC having progressive or symptomatic disease.…
To evaluate recurrent dysphagia, due to tissue overgrowth or migration, of the SX-Ella stent Esophageal HV in patients with dysphagia from inoperable carcinoma of the distal esophagus or cardia.
The aim of this study is to evaluate the feasibility of cryoablation in patients with dysplastic squamous epithelium in the esophagus.
The main objective of this pilot study is to determine PKI concentration in tumor tissue after approximately two weeks of treatment.